WO2002032926A3 - Haplotypes of the ccbp2 gene - Google Patents

Haplotypes of the ccbp2 gene Download PDF

Info

Publication number
WO2002032926A3
WO2002032926A3 PCT/US2001/042685 US0142685W WO0232926A3 WO 2002032926 A3 WO2002032926 A3 WO 2002032926A3 US 0142685 W US0142685 W US 0142685W WO 0232926 A3 WO0232926 A3 WO 0232926A3
Authority
WO
WIPO (PCT)
Prior art keywords
haplotypes
ccbp2
gene
disclosed
ccbp2 gene
Prior art date
Application number
PCT/US2001/042685
Other languages
French (fr)
Other versions
WO2002032926A2 (en
Inventor
Brock Armstrong
Amir Kazemi
Beena Koshy
Original Assignee
Genaissance Pharmaceuticals
Brock Armstrong
Amir Kazemi
Beena Koshy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genaissance Pharmaceuticals, Brock Armstrong, Amir Kazemi, Beena Koshy filed Critical Genaissance Pharmaceuticals
Priority to AU2002230405A priority Critical patent/AU2002230405A1/en
Publication of WO2002032926A2 publication Critical patent/WO2002032926A2/en
Publication of WO2002032926A3 publication Critical patent/WO2002032926A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Abstract

Novel genetic variants of the Chemokine Binding Protein 2 (CCBP2) gene are described. Various genotypes, haplotypes, and haplotype pairs that exist in the general United States population are disclosed for the CCBP2 gene. Compositions and methods for haplotyping and/or genotyping the CCBP2 gene in an individual are also disclosed. Polynucleotides defined by the haplotypes disclosed herein are also described.
PCT/US2001/042685 2000-10-12 2001-10-12 Haplotypes of the ccbp2 gene WO2002032926A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002230405A AU2002230405A1 (en) 2000-10-12 2001-10-12 Haplotypes of the ccbp2 gene

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23963800P 2000-10-12 2000-10-12
US60/239,638 2000-10-12

Publications (2)

Publication Number Publication Date
WO2002032926A2 WO2002032926A2 (en) 2002-04-25
WO2002032926A3 true WO2002032926A3 (en) 2003-02-06

Family

ID=22903051

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/042685 WO2002032926A2 (en) 2000-10-12 2001-10-12 Haplotypes of the ccbp2 gene

Country Status (2)

Country Link
AU (1) AU2002230405A1 (en)
WO (1) WO2002032926A2 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5474796A (en) * 1991-09-04 1995-12-12 Protogene Laboratories, Inc. Method and apparatus for conducting an array of chemical reactions on a support surface

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5474796A (en) * 1991-09-04 1995-12-12 Protogene Laboratories, Inc. Method and apparatus for conducting an array of chemical reactions on a support surface

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE GENBANK [online] NATIONAL LIBRARY OF MEDICINE, NIH (BETHESDA, MD, USA); 6 September 2000 (2000-09-06), MUZNY ET AL.: "Nucleotide sequences", XP002951943, accession no. NCBI Database accession no. (AC010192) *
NIBBS ET AL.: "Cloning and characterization of a novel promiscuous human beta-chemokine receptor D6", THE JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 272, no. 51, 19 December 1997 (1997-12-19), pages 32078 - 32083, XP000857635 *

Also Published As

Publication number Publication date
AU2002230405A1 (en) 2002-04-29
WO2002032926A2 (en) 2002-04-25

Similar Documents

Publication Publication Date Title
WO2001090122A3 (en) Haplotypes of the ctla4 gene
WO2002026764A3 (en) Haplotypes of the ccr6 gene
WO2002018414A3 (en) Haplotypes of the bf gene
WO2002032926A3 (en) Haplotypes of the ccbp2 gene
WO2001092278A3 (en) Haplotypes of the rlbp1 gene
WO2002090512A3 (en) Haplotypes of the nnmt gene
WO2001077363A3 (en) Haplotypes of the impdh2 gene
WO2001087909A3 (en) Haplotypes of the aanat gene
WO2001090127A3 (en) Haplotypes of the hoxd3 gene
WO2001090118A3 (en) Haplotypes of the edn2 gene
WO2002002580A3 (en) Haplotypes of the etfb gene
WO2001087908A3 (en) Haplotypes of the ccr3 gene
WO2002012499A3 (en) Haplotypes of the ntf3 gene
WO2002050098A3 (en) Haplotypes of the prlr gene
WO2002016399A3 (en) Haplotypes of the tacr1 gene
WO2002094850A3 (en) Haplotypes of the gnrh2 gene
WO2001094362A3 (en) Haplotypes of the acp2 gene
WO2002055534A3 (en) Haplotypes of the f2rli gene
WO2002090378A3 (en) Haplotypes of the ces2 gene
WO2002022651A3 (en) Haplotypes of the ccr8 gene
WO2001087907A3 (en) Haplotypes of the osm gene
WO2002032924A3 (en) Haplotypes of the chrm5 gene
WO2001092279A3 (en) Haplotypes of the aldh5 gene
WO2002038586A3 (en) Haplotypes of the il6 gene
WO2001090126A3 (en) Haplotypes of the snap29 gene

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WPC Withdrawal of priority claims after completion of the technical preparations for international publication

Ref country code: WO

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP